Search

Displaying results 9901 - 9910 of 10000 in total
  1. Drug

    Adomiparin

    go.drugbank.com/drugs/DB06005
    Investigational

  2. Drug

    ARQ 171

    go.drugbank.com/drugs/DB06034
    Investigational

  3. Drug

    Exisulind

    go.drugbank.com/drugs/DB06246
    Investigational

  4. Drug

    Ocaperidone

    go.drugbank.com/drugs/DB06229
    Experimental

  5. Drug

    VA-MENGOC-BC®

    go.drugbank.com/drugs/DB15800
    Experimental

    The OMVs contain over 100 proteins, and are derived from meningococcal group B and capsular polysaccharide of meningococcal group C.

  6. Drug

    Pazopanib

    go.drugbank.com/drugs/DB06589
    ApprovedInvestigational

    Pazopanib is a small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity. It is developed by GlaxoSmithKline and was FDA approved on October 19, 2009.

  7. Drug

    DP-VPA

    go.drugbank.com/drugs/DB05821
    Investigational

    DP-VPA is D-Pharm's proprietary lipid modified version of valproic acid (VPA) that demonstrate that DP-VPA is well-tolerated in patients with resistant epilepsy and has a marked effect on reducing seizure frequency.

  8. Drug

    Bimoclomol

    go.drugbank.com/drugs/DB06258
    Experimental

    Bimoclomol is an investigational drug that induces stress proteins and has cytoprotective effects.

  9. Drug

    Tesofensine

    go.drugbank.com/drugs/DB06156
    Investigational

  10. Drug

    Latiglutenase

    go.drugbank.com/drugs/DB06326
    Investigational